Acadia Pharmaceuticals Inc financial data

Symbol
ACAD on Nasdaq
Industry
Pharmaceutical Preparations
Location
12830 El Camino Real, Suite 400, San Diego, CA
State of incorporation
Delaware
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2024 - Aug 7, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 223 % -28.1%
Quick Ratio 19.3 % +160%
Debt-to-equity 77.5 % +38.7%
Return On Equity 6.89 %
Return On Assets 3.88 %
Operating Margin -10.1 % +76.6%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 166M shares +1.31%
Common Stock, Shares, Outstanding 166M shares +1.53%
Entity Public Float 2.9B USD +70.6%
Common Stock, Value, Issued 16K USD 0%
Weighted Average Number of Shares Outstanding, Basic 166M shares +1.28%
Weighted Average Number of Shares Outstanding, Diluted 166M shares +0.68%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 726M USD +40.4%
Revenue from Contract with Customer, Excluding Assessed Tax 891M USD +61.7%
Research and Development Expense 360M USD +26.2%
Costs and Expenses 868M USD +27.9%
Operating Income (Loss) 22.8M USD +902%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 45.7M USD +486%
Income Tax Expense (Benefit) 15.2M USD +209%
Net Income (Loss) Attributable to Parent 30.6M USD +2897%
Earnings Per Share, Basic 0.18 USD/shares +1900%
Earnings Per Share, Diluted 0.18 USD/shares +1900%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 177M USD +64.1%
Accounts Receivable, after Allowance for Credit Loss, Current 104M USD +26.7%
Inventory, Net 86.1M USD +509%
Assets, Current 729M USD +48%
Property, Plant and Equipment, Net 4.14M USD -20.2%
Operating Lease, Right-of-Use Asset 52.4M USD +0.02%
Other Assets, Noncurrent 476K USD -95.8%
Assets 914M USD +42.2%
Accounts Payable, Current 19.9M USD +5.69%
Employee-related Liabilities, Current 26M USD +2.48%
Accrued Liabilities, Current 318M USD +88%
Liabilities, Current 338M USD +79.8%
Deferred Income Tax Liabilities, Net 12.4M USD -6.34%
Operating Lease, Liability, Noncurrent 47.2M USD -5.21%
Other Liabilities, Noncurrent 12.4M USD +33.6%
Liabilities 397M USD +60.9%
Accumulated Other Comprehensive Income (Loss), Net of Tax -339K USD +36.6%
Retained Earnings (Accumulated Deficit) -2.38B USD +1.27%
Stockholders' Equity Attributable to Parent 517M USD +30.5%
Liabilities and Equity 914M USD +42.2%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 29.1M USD
Net Cash Provided by (Used in) Financing Activities 1.04M USD -28.9%
Net Cash Provided by (Used in) Investing Activities -14M USD -107%
Common Stock, Shares Authorized 225M shares 0%
Common Stock, Shares, Issued 166M shares +1.53%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 16.1M USD -90.9%
Deferred Tax Assets, Valuation Allowance 482M USD +0.18%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Deferred Tax Assets, Gross 494M USD +0.01%
Operating Lease, Liability 57.7M USD -2.01%
Depreciation 242K USD -43.2%
Payments to Acquire Property, Plant, and Equipment 0 USD -100%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 30.8M USD +4065%
Lessee, Operating Lease, Liability, to be Paid 66.5M USD -3.64%
Property, Plant and Equipment, Gross 14.2M USD +0.35%
Operating Lease, Liability, Current 10.5M USD +15.6%
Lessee, Operating Lease, Liability, to be Paid, Year Two 10.2M USD +9.39%
Lessee, Operating Lease, Liability, to be Paid, Year One 10.8M USD +17.2%
Operating Lease, Weighted Average Discount Rate, Percent 0.05 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 8.8M USD -13.1%
Lessee, Operating Lease, Liability, to be Paid, Year Three 9.94M USD +14.6%
Deferred Tax Assets, Operating Loss Carryforwards 149M USD -34%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5M shares 0%
Unrecognized Tax Benefits 37.1M USD +94.7%
Lessee, Operating Lease, Liability, to be Paid, Year Four 9.52M USD +13.9%
Operating Lease, Payments 9.82M USD +5.26%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 5.29M USD
Deferred Tax Assets, Net of Valuation Allowance 6.8M USD +467%
Share-based Payment Arrangement, Expense 67M USD +7.05%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%